EDCTP—Partnership between Europe and Developing Countries to Conduct Clinical Trials

TheGlobal Health European and Developing Countries Clinical Trials Joint Undertaking(GH EDCTP3 JU, 2021-2031) is a partnership between the European Union and Africa in global health.

GH EDCTP3 JU is the third EDCTP program and is an institutionalized Article 187 partnership that builds on the success of the previous programs, EDCTP 1 andEDCTP 2. The GH EDCTP3 JU aims to contribute to the development of new or improved health technologies for the identification, treatment, and prevention of neglected and poverty-related infectious diseases, including (re)emerging diseases affecting sub-Saharan Africa.

In addition, GH EDCTP3 JU will fund activities to build research capacity in Africa, supporting researchers' careers and strengthening national health research systems, improving the capacity of sub-Saharan African countries to identify and respond to health challenges related to infectious diseases.

The overall objectives of the EDCTP3 JU are:

1. Reduce the socioeconomic impact of infectious diseases in sub-Saharan Africa by promoting the development and adoption of new or improved health technologies, and
2. Enhance health security in sub-Saharan Africa and globally by strengthening preparedness and response capacity for infectious disease control, based on research and innovation.

The GH EDCTP3 JU has a total estimated budget of €1.6 billion. Financial contributions come from the EU (€0.8 billion), European and African members of the EDCTP (€0.43 billion), and contributing partners such as philanthropic organizations and industry (€0.4 billion). Portugal was a founding member of EDCTP and is also a member of the new GH EDCTP3 JU program, represented by FCT andAICIB.

The priority areas of the GH EDCTP3 JU are described in the Strategic Research and Innovation Agenda.

For more information on the GH EDCTP3 JU, please visit the interim GH EDCTP3 JU webpage.

Funding opportunities

The GH EDCTP3 JU funding opportunities include, on an annual basis, the launch of joint Calls for proposals for the funding of clinical research, capacity building, and/or networking in the priority areas of EDCTP3. Previous editions can be consulted at this link.

NOTE: The Lusophone Platform for Clinical Research and Biomedical Innovation, PLICIB, created by AICIB with the support of FCT and co-financed by EDCTP3, aims to provide effective support to the Portuguese scientific community, together with the scientific community in Portuguese-speaking African countries (PALOP) and neighboring countries, for greater competitiveness in GH EDCTP3 JU funding opportunities.

Past Events

• Webinar on GH EDCTP3 funding opportunities – part 1: March 23. Recording of the infoday and PowerPoint presentation.
• Webinar on GH EDCTP3 funding opportunities – part 2: April 12. Recording of the infoday.
• National webinar on GH EDCTP3 JU funding opportunities organized by FCT and AICIB: April 21, 10:30 a.m. (GMT). More information here.
• EDCTP Forum: From November 7 to 10, 2023, the 11th EDCTP Forum, organized by France, will be held in Paris.
  • Submission of abstracts for oral presentations or e-poster presentations of original contributions on global health research. Deadline: May 3
  • Four awards will be presented to recognize outstanding individuals and research teams who have achieved significant accomplishments in their field. Deadline: May 31
  • More information here.

Upcoming Events

The twelfth edition of the EDCTP Forum, under the theme "Better health through global research partnerships," will take place in Kigali, Rwanda, from June 15 to 20, 2025, at the Kigali Convention Center. More information is available at this link.